Cardiovascular Diseases Clinical Trial
To determine the association between flavonoids intake and the prevention of incident cardiovascular disease (CVD).
BACKGROUND:
Basic science, clinical observation, and epidemiologic studies have all contributed to an
emerging body of evidence on the potential role of flavonoids, a group of polyphenolic
compounds with antioxidant properties, in the prevention of cardiovascular disease. However,
the few existing studies on flavonoids or its food sources have provided inconsistent
results, usually focusing on the primary prevention of coronary heart disease mortality. The
study used the small grant mechanism (R03) to analyze previously collected data.
DESIGN NARRATIVE:
The investigators examined whether flavonoid intake was associated with the risk of incident
CVD, and whether specific food sources of flavonoids--including tea, onions, apples, red
wine, and other foods--were associated with the risk of incident CVD. The investigators
processed and analyzed previously collected data of 39,876 middle-aged and older women free
of CVD; the Women's Antioxidant Cardiovascular Study (WACS), a prospective study of 8,171
middle-aged and older women with pre-existing CVD or more than three coronary risk factors;
the Normative Aging Study (NAS), a prospective study of 2,280 middle-aged and older men; and
the Boston Area Health Study (BAHS), a case-control study of first nonfatal myocardial
infarction in men and women aged less than 76 years. Using data from semiquantitative food
frequency questionnaires administered in each study, the investigators determined individual
intake of flavonoids and its food sources. Unlike previous studies, they examined flavonoids
in relation to both the primary and secondary prevention of incident cardiovascular disease
(CVD), consisting of confirmed cases of nonfatal myocardial infarction (Ml), nonfatal
stroke, revascularization procedures, and CVD death.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|